Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
about
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragmentAntitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts.Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties.Soluble plasma HLA peptidome as a potential source for cancer biomarkersTargeting hepatitis B virus-infected cells with a T-cell receptor-like antibody.T Cell Receptor Engineering and Analysis Using the Yeast Display Platform.Recent advances in tumour antigen-specific therapy: in vivo veritas.T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens.Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies iNovel antibodies as anticancer agents.Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies.Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development.TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells.T-cell-receptor-like antibodies - generation, function and applications.PLGA-Listeriolysin O microspheres: Opening the gate for cytosolic delivery of cancer antigens.Immunological Aspects of Malignant Gliomas.Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity.Epitopes of the class I major histocompatibility complex (MHC-I) recognized in the syngeneic or allogeneic context predominantly linked to antigenic peptide loading to its binding groove.Assessment of CD8 involvement in T cell clone avidity by direct measurement of HLA-A2/Mage3 complex density using a high-affinity TCR like monoclonal antibody.Targeting an extracellular epitope of the human multidrug resistance protein 1 (MRP1) in malignant cells with a novel recombinant single chain Fv antibody.TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexesConstruction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H.MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing.TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies.Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition.
P2860
Q27322455-F6E5F3E6-B022-4754-872D-B61B0E38CF36Q33357299-A9BF741B-7C72-432C-BB81-C2C2263C80D1Q33506656-398B936B-A91E-4803-B403-E13281651B18Q34279102-CFFA328B-2712-4BA8-8CD9-74E324DB237BQ34741725-054165DE-88A0-4D8F-9C65-748D56B6E993Q35659205-9B288291-4F1D-4FB0-A936-52B01BA5FDA5Q35896209-D610C8B2-C47D-4793-8136-5E2E1099E1FEQ36297606-55833AA2-3AA0-47EB-A33F-7999ABAB6982Q36317151-D0991423-241F-47A6-A5C8-B3339E152C37Q36399192-6656520B-0CC5-4D42-B98A-09DF6EA3B5F8Q36832141-44953F5D-4A79-4821-A399-1EA2811B1368Q36921315-E2A545A6-9982-423F-9267-D10CCE9101D4Q37192915-76E4CEAF-F447-45BD-BA70-ECB5BBB4001CQ37844333-DF68DB4B-2BB6-4FF8-8C14-1529232D2928Q37952806-468F357D-E43A-4E4B-AD03-71742C951F53Q37987723-94D8386B-FA7F-4A71-BC6E-4E647221AEFDQ38793294-93CC4A33-6593-489B-B86D-584DF2C75F7DQ38870994-69C0C868-0FB5-4225-869B-3620D110D84AQ40196365-631F7C7A-C6BA-4A1C-9271-10F26111F649Q40249631-18DF14B5-2B2E-4DDA-BF16-BEFB0E078551Q40373377-B9424873-79C3-443B-B522-0E78DB0F3608Q40550562-E90F064B-56DB-437F-ACB0-784B1191CC73Q42724811-C6D08294-1D7E-4FEF-A9C7-036FEEC4A89AQ43448245-57F192CB-AA46-4E86-BECD-93267394C94AQ44134119-7554CD73-231C-4284-B299-5785B4F7950EQ52691571-7FACE973-DDA9-4357-AEA1-210B33ED1544Q53631492-02E7B6A9-8907-4F60-9232-A5598D2C82FF
P2860
Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Direct phenotypic analysis of ...... human recombinant antibodies.
@ast
Direct phenotypic analysis of ...... human recombinant antibodies.
@en
type
label
Direct phenotypic analysis of ...... human recombinant antibodies.
@ast
Direct phenotypic analysis of ...... human recombinant antibodies.
@en
prefLabel
Direct phenotypic analysis of ...... human recombinant antibodies.
@ast
Direct phenotypic analysis of ...... human recombinant antibodies.
@en
P2093
P1476
Direct phenotypic analysis of ...... human recombinant antibodies.
@en
P2093
Cyril J Cohen
Offra Sarig
Steven Jacobson
Utano Tomaru
Yoram Reiter
Yoshihisa Yamano
P304
P356
10.4049/JIMMUNOL.170.8.4349
P407
P577
2003-04-01T00:00:00Z